The enforcement action
CapsulCN, a PRC-based manufacturer and exporter of pill-pressing machines, capsule filling equipment, and pharmaceutical machinery, was indicted by the U.S. Department of Justice for knowingly exporting equipment used in illicit fentanyl and counterfeit pill production. The company operated through multiple brand names and phantom entities, deliberately obscuring the true ownership and control structure to continue exporting equipment that enables drug manufacturing operations worldwide.
Piercing the corporate veil
Sayari analysts used intellectual property and trademark records — a data source often overlooked in corporate investigations — to trace the CapsulCN brand to its true owner: Zhejiang Shanfan Machinery. Trademark registrations, patent filings, and domain records reveal the corporate reality behind the phantom entities that CapsulCN used to present multiple apparently independent businesses to international customers. This IP-first investigative approach demonstrates how non-traditional data sources can pierce corporate structures designed to resist conventional analysis.
The equipment supply chain
Trade data reveals the scope of CapsulCN’s global distribution network — shipping pill presses, tablet coating machines, and capsule fillers to customers across North America, Latin America, Europe, and Southeast Asia. The investigation traces the logistics infrastructure connecting Chinese manufacturing to end users, identifying intermediary distributors and shipping agents that facilitate the export of equipment used in illicit drug production. Each node in the supply chain represents a potential intervention point for enforcement agencies.
Why this matters
The fentanyl crisis is not only a chemical problem — it is an equipment problem. Pill presses and capsule machines are essential production infrastructure. Disrupting the equipment supply chain is a complementary strategy to precursor chemical interdiction. This investigation demonstrates how corporate records, intellectual property data, and trade records together can map the full equipment supply chain from manufacturer to end user — enabling enforcement agencies and compliance teams to identify and disrupt the infrastructure behind illicit drug production.
Sayari’s Commercial World Model covers 10.6B+ primary-source records across 250+ jurisdictions. The platform resolves entity identities, traces ownership chains, and delivers evidence-grade intelligence that enables analysts to conduct investigations like this one at scale — from corporate registries and trade manifests to beneficial ownership records and sanctions lists.